Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 (4 Ethyl 3 iodophenyl) 2 methylpropanoic acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for Alectinib intermediate offering high yield and cost efficiency. Ideal for pharmaceutical intermediate supply chain optimization.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Optimized synthesis of 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid via copper catalysis. Reduces heavy metal residue and cost for API manufacturing.